The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksINS.L Regulatory News (INS)

  • There is currently no data for INS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grants to Directors under the Instem LTIP

26 Feb 2018 07:00

RNS Number : 8537F
Instem plc
26 February 2018
 

 

Instem plc

("Instem" or the "Company")

 

Grants to Directors under the Instem Long Term Incentive Plan ('LTIP')

 

Instem plc (AIM: INS), a leading provider of IT solutions to the global life sciences market, announces that Chief Executive Officer, Phil Reason and Chief Financial Officer, Nigel Goldsmith have each been granted nil-cost options over 80,000 Instem ordinary shares of 10p ("Ordinary Shares") under the Company's long-term incentive plan ("LTIP").

 

These 160,000 share options will become exercisable in 2021, subject to meeting share price targets, pursuant to the rules of the LTIP, which was approved by the Board on 22 February 2018. Following exercise of the options, the resulting shares will then be subject to a minimum 12-month holding period.

 

After these grants of options, Phil Reason and Nigel Goldsmith hold a total of 384,606 and 217,500 share options, respectively whilst their holdings in Ordinary Shares remain unchanged at 665,287 and Nil, respectively.

 

 

 

For further information, please contact:

 

Instem plc

+44 (0) 1785 825 600

Phil Reason, CEO

 

Nigel Goldsmith, CFO

 

 

 

 

N+1 Singer (Nominated Adviser & Broker)

 

+44 (0) 20 7496 3000

Richard Lindley

James White

Rachel Hayes

 

 

 

 

Walbrook Financial PR

+44 (0) 20 7933 8000

Paul Cornelius

instem@walbrookpr.com

Helen Cresswell

Sam Allen

 

 

 

 

About Instem

 

Instem is a leading provider of IT solutions & services to the life sciences market delivering compelling solutions for Study Management and Data Collection; Regulatory Solutions for Submissions and Compliance; and Informatics-based Insight Generation.

 

Instem solutions are in use by customers worldwide and enable our clients to bring life enhancing products to market faster.

 

Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.

 

Instem supports over 500 clients through offices in the United States, United Kingdom, France, Japan, China and India.

 

To learn more about Instem solutions and its mission, please visit instem.com.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Phil Reason

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Instem plc

b)

 

LEI

 

 

213800PILYUFNNROQX68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Options over Ordinary Shares of 10p each

 

 

ISIN Code: GB00B3TQCK30

 

b)

 

Nature of the transaction

 

 

(i) Grant of options over Ordinary Shares

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s):

 

Volume(s):

(i) Nil

 

80,000

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

N/A

e)

 

Date of the transaction

 

 

22/02/2018

f)

 

Place of the transaction

 

 

Off market

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Nigel Goldsmith

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Instem plc

b)

 

LEI

 

 

213800PILYUFNNROQX68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Options over Ordinary Shares of 10p each

 

 

ISIN Code: GB00B3TQCK30

 

b)

 

Nature of the transaction

 

 

(ii) Grant of options over Ordinary Shares

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s):

 

Volume(s):

(ii) Nil

 

80,000

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

N/A

e)

 

Date of the transaction

 

 

22/02/2018

f)

 

Place of the transaction

 

 

Off market

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUVRARWNAUUAR
Date   Source Headline
15th Feb 201811:05 amRNSSecond Price Monitoring Extn
15th Feb 201811:00 amRNSPrice Monitoring Extension
29th Jan 20187:00 amRNSDirector/PDMR Shareholding
23rd Jan 20185:27 pmRNSHolding(s) in Company
16th Jan 20187:01 amRNSContract Win
16th Jan 20187:00 amRNSTrading Statement
5th Oct 201711:30 amRNSHolding(s) in Company
29th Sep 201712:17 pmRNSIssue of Equity & Total Voting Rights
26th Sep 20177:00 amRNSHalf-year Report
21st Sep 20175:57 pmRNSHolding(s) in Company
4th Sep 20177:00 amRNSNotice of Results
31st May 20178:39 amRNSPayment of consideration and total voting rights
19th May 20175:00 pmRNSHolding(s) in Company
18th May 201710:24 amRNSResult of AGM
9th May 20172:25 pmRNSIssue of Equity and Total Voting Rights
28th Apr 20175:12 pmRNSHolding(s) in Company
26th Apr 20177:00 amRNSUS Government Contract
21st Apr 20177:00 amRNSPosting of Annual Report and Notice of AGM
4th Apr 201710:10 amRNSHolding(s) in Company
4th Apr 201710:10 amRNSHolding(s) in Company
29th Mar 20173:46 pmRNSHolding(s) in Company
28th Mar 20177:00 amRNSFinal Results
9th Mar 20177:00 amRNSInvestor Teach-in
7th Mar 20177:00 amRNSNotice of Results
16th Jan 20177:00 amRNSTrading Statement
9th Jan 20172:30 pmRNSAppointment of Chief Operating Officer
9th Jan 20177:00 amRNSGrowth & Innovation Forum
20th Dec 20165:23 pmRNSHolding(s) in Company
19th Dec 20164:58 pmRNSHolding(s) in Company
15th Dec 20167:00 amRNSRevised Earn Out Settlement
21st Nov 20167:00 amRNSTrading Statement
22nd Sep 20167:00 amRNSHolding(s) in Company
21st Sep 20168:08 amRNSIssue of Equity
19th Sep 20167:00 amRNSHalf-year Report
5th Sep 20163:40 pmRNSEarnings Enhancing Acquisition of Notocord®
24th Aug 20167:00 amRNSTrading Update and Notice of Half-Year Results
9th Jun 20165:32 pmRNSIssue of Equity
1st Jun 20161:55 pmRNSHolding(s) in Company
31st May 20167:00 amRNSAcquisition, Issue of Equity & Total Voting Rights
26th May 20165:42 pmRNSResult of AGM
19th May 20162:31 pmRNSHolding(s) in Company
16th May 20164:30 pmRNSIssue of Equity and Total Voting Rights
7th Apr 20169:42 amRNSHolding(s) in Company
5th Apr 20167:00 amRNSFinal Results
4th Apr 20167:00 amRNSFour SEND related contract wins
15th Mar 20167:00 amRNSTwo SEND Submit Contract Wins
14th Mar 20167:00 amRNSNotice of Results
3rd Mar 201610:56 amRNSHolding(s) in Company
29th Feb 20169:56 amRNSHolding(s) in Company (Correction)
26th Feb 20169:26 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.